These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 29908318
1. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy. Pucci S, Ciccarelli F, De Pasquale T, Illuminati I, D'Alò S. Ann Allergy Asthma Immunol; 2018 Sep; 121(3):376-377. PubMed ID: 29908318 [No Abstract] [Full Text] [Related]
2. [Results of hyposensitization with bee and wasp venom]. Adolph J, Dehnert I, Fischer JF, Wenz W. Z Erkr Atmungsorgane; 1986 Sep; 166(1):119-24. PubMed ID: 3953108 [Abstract] [Full Text] [Related]
3. Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts. Brunetto S, Gammeri L, Buta F, Gangemi S, Ricciardi L. Allergy Asthma Proc; 2024 May 01; 45(3):195-200. PubMed ID: 38755779 [Abstract] [Full Text] [Related]
4. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy. von Moos S, Graf N, Johansen P, Müllner G, Kündig TM, Senti G. Int Arch Allergy Immunol; 2013 May 01; 160(1):86-92. PubMed ID: 22948338 [Abstract] [Full Text] [Related]
6. Venom immunotherapy for preventing allergic reactions to insect stings. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN. Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950 [Abstract] [Full Text] [Related]
7. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy. Rosman Y, Nashef F, Cohen-Engler A, Meir-Shafrir K, Lachover-Roth I, Confino-Cohen R. Int Arch Allergy Immunol; 2019 Oct 17; 180(2):128-134. PubMed ID: 31216540 [Abstract] [Full Text] [Related]
8. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy. Gawlik R, Glück J, Jawor B, Rogala B. Immunopharmacol Immunotoxicol; 2015 Oct 17; 37(4):375-9. PubMed ID: 26181651 [Abstract] [Full Text] [Related]
9. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population. Roesch A, Boerzsoenyi J, Babilas P, Landthaler M, Szeimies RM. J Dtsch Dermatol Ges; 2008 Apr 17; 6(4):292-7. PubMed ID: 18042250 [Abstract] [Full Text] [Related]
10. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Ann Allergy; 1994 Nov 17; 73(5):423-8. PubMed ID: 7978535 [Abstract] [Full Text] [Related]
11. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Wenzel J, Meissner-Kraemer M, Bauer R, Bieber T, Gerdsen R. Allergy; 2003 Nov 17; 58(11):1176-9. PubMed ID: 14616130 [Abstract] [Full Text] [Related]
12. [Desensitization of allergy to hymenoptera venoms]. Przybilla B, Ruëff F. Wien Med Wochenschr; 1999 Nov 17; 149(14-15):421-8. PubMed ID: 10584286 [Abstract] [Full Text] [Related]
19. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy]. Steiss JO, Hüls G, Gortner L, Lindemann H. Klin Padiatr; 2004 Apr 17; 216(2):79-82. PubMed ID: 15106079 [Abstract] [Full Text] [Related]
20. [Immunotherapy against hymenoptera venom: report of ten patients]. Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM. Rev Med Chil; 2007 Dec 17; 135(12):1566-71. PubMed ID: 18357358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]